YEARS Algorithm for Pulmonary Embolism (PE)
Helps rule out pulmonary embolism; also validated in pregnant patients with clinically suspected PE.
Use in hemodynamically stable patients ≥18 years old.
Take note of the following exclusion criteria:
- Treatment with therapeutic doses of anticoagulants initiated 24 hours or more before eligibility assessment.
- Life expectancy less than 3 months.
- Geographic inaccessibility precluding follow-up.
- Pregnancy (be sure to use pregnancy-adapted YEARS algorithm in the calc).
- Allergy to intravenous contrast agent.
Result:
Tom van der Hulle, MD, is an internist in the department of thrombosis and hemostasis at Leiden University Medical Centre in Leiden, Netherlands. His primary research interests involve hematology, oncology, and pulmonology.
Menno Huisman, MD, PhD, FESC, is a professor of medicine in the department of medicine - thrombosis and hemostasis at Leiden University Medical Center in The Netherlands. He is an internist with specialty in cardiovascular medicine. Dr. Huisman’s primary research is focused on the clinical diagnosis and treatment of venous and arterial thromboembolic disorders.
- Daniel Runde, MD
- Matthew Negaard, MD